PHA622: Molecular Therapeutics

This unit introduces models of new and experimental drug regimes, recognising the concept of the molecular basis of therapy and new approaches to biomedical research. It provides knowledge of molecular biology and its application to elucidate mechanisms of various disease states and information that may be used in new treatments. Topics to be studied will include the human genome, the exploration and manipulation of genes, the molecular basis of disease and pharmaceutical biotechnology and case studies of major disease states.

Related Unit Codes:

Points	2
Enrolment Options	Murdoch: T3-internal
Contact Time	Lectures/tutorials: 3 hours per week; laboratories: 3 hours per week.
Prerequisites	Enrolment in the Master of Pharmacy; Completion of 1st Year of Master of Pharmacy; PHA603 Pharmaceutical Chemistry III.
School	School of Nursing and Midwifery
Unit Coordinator	Dr Ian Mullaney Position: Senior Lecturer in Pharmacology E-mail: I.Mullaney@murdoch.edu.au Location: Murdoch Campus Amenities Room 3.005 Phone: Prefix: +618 9360 1236
Unit Contacts	Contact Phone Prefix: +618 Location Explanation of Location Codes Teaching Period(s) Dr Ian Mullaney Senior Lecturer in Pharmacology (I.Mullaney@murdoch.edu.au) 9360 1236 Murdoch Campus Amenities Room 3.005 MURDOCH T3: Internal (16/08/2010 - 19/11/2010)

Check the Teaching Timetable Search for a Booklist for PHA622 View Reserve and ECMS resources for PHA622 View further details in the Handbook

Key to Offshore Campus Location abbreviations: APMISIN Asia Pacific Management Institute (Singapore) CEJTOKYO Chiropractic Education Japan (Tokyo) JKURASHIKI NET Corporation (Kurashiki, Japan) KDUPG KDU College (Penang, Malaysia) KDUPJ KDU College (Petaling Jaya, Malaysia) SGP-REPOLY Republic Polytechnic (Singapore) SMANUFED Singapore Manufacturing Federation ZHENGZHOU Zhengzhou University (China)